Cencora Inc (COR)
232.30
-1.59
(-0.68%)
USD |
NYSE |
Nov 05, 09:43
Cencora Revenue (Quarterly): 74.24B for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 74.24B |
| March 31, 2024 | 68.41B |
| December 31, 2023 | 72.25B |
| September 30, 2023 | 68.92B |
| June 30, 2023 | 66.95B |
| March 31, 2023 | 63.46B |
| December 31, 2022 | 62.85B |
| September 30, 2022 | 61.17B |
| June 30, 2022 | 60.06B |
| March 31, 2022 | 57.72B |
| December 31, 2021 | 59.63B |
| September 30, 2021 | 58.91B |
| June 30, 2021 | 53.41B |
| March 31, 2021 | 49.15B |
| December 31, 2020 | 52.52B |
| September 30, 2020 | 49.24B |
| June 30, 2020 | 45.37B |
| March 31, 2020 | 47.42B |
| December 31, 2019 | 47.86B |
| September 30, 2019 | 45.64B |
| June 30, 2019 | 45.24B |
| March 31, 2019 | 43.32B |
| December 31, 2018 | 45.39B |
| September 30, 2018 | 43.30B |
| June 30, 2018 | 43.14B |
| Date | Value |
|---|---|
| March 31, 2018 | 41.03B |
| December 31, 2017 | 40.47B |
| September 30, 2017 | 39.12B |
| June 30, 2017 | 38.71B |
| March 31, 2017 | 37.15B |
| December 31, 2016 | 38.17B |
| September 30, 2016 | 37.56B |
| June 30, 2016 | 36.88B |
| March 31, 2016 | 35.70B |
| December 31, 2015 | 36.71B |
| September 30, 2015 | 35.47B |
| June 30, 2015 | 34.23B |
| March 31, 2015 | 32.67B |
| December 31, 2014 | 33.59B |
| September 30, 2014 | 31.59B |
| June 30, 2014 | 30.35B |
| March 31, 2014 | 28.46B |
| December 31, 2013 | 29.18B |
| September 30, 2013 | 24.47B |
| June 30, 2013 | 21.91B |
| March 31, 2013 | 20.52B |
| December 31, 2012 | 21.06B |
| September 30, 2012 | 19.06B |
| June 30, 2012 | 19.33B |
| March 31, 2012 | 19.71B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
45.37B
Minimum
Jun 2020
74.24B
Maximum
Jun 2024
58.92B
Average
59.63B
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| Cardinal Health Inc | 52.28B |
| McKesson Corp | 79.28B |
| Weed Inc | -- |
| Pineapple Inc | 0.1051M |
| Zomedica Corp | 6.131M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 483.46M |
| Total Expenses (Quarterly) | 73.49B |
| EPS Diluted (Quarterly) | 2.42 |
| Enterprise Value | 47.40B |
| Gross Profit Margin (Quarterly) | 3.25% |
| Profit Margin (Quarterly) | 0.65% |
| Earnings Yield | 3.96% |
| Operating Earnings Yield | 6.44% |
| Normalized Earnings Yield | 4.866 |